Study sample (n = 1403) | ||||
---|---|---|---|---|
1C (n = 394) n (%) or mean | SC (n = 1009) n (%) or mean | p value | Missing data | |
PATIENT CHARACTERISTICS | ||||
Age at diagnosis | 60.8 | 60.2 | 0.055 | 0 % |
Menopausal at diagnosis | 0.150 | 6.4 % | ||
Yes | 297 (81 %) | 794 (84 %) | ||
No | 71 (19 %) | 151 (16 %) | ||
BMI | 24.8 | 25.8 | <0.001 | 3.2 % |
HRT use at diagnosis | <0.001 | 5.1 % | ||
No | 280 (75 %) | 802 (84 %) | ||
Yes | 93 (25 %) | 156 (16 %) | ||
Oral contraceptive use | 0.145 | 3.1 % | ||
No | 78 (21 %) | 239 (24 %) | ||
Yes | 300 (79 %) | 742 (76 %) | ||
Parity | ||||
Nulliparous | 61 (15 %) | 158 (16 %) | 0.997 | 2.2 % |
Number of births, parous women | 2.13 | 2.14 | 0.816 | 0 % |
Age at first birth, parous women | 25.7 | 25.4 | 0.341 | 0 % |
Family history of breast cancer (first degree) | 0.029 | 7.8 % | ||
No | 284 (77 %) | 762 (82 %) | ||
Yes | 84 (23 %) | 162 (18 %) | ||
MAMMOGRAPHIC CHARACTERISTICS | ||||
Time (months) from measure to diagnosis | 15.3 (median) | 24.6 (median) | <0.001 | |
Mammographic percent density | 23.5 (median) | 17.6 (median) | <0.001 | |
TUMOR CHARACTERISTICS | n (%) or mean | n (%) or mean | ||
Tumor size, mm | 19.5 | 15.6 | <0.001 | 7.3 % |
Lymph node metastasis | <0.001 | 0.4 % | ||
No | 356 (91 %) | 960 (96 %) | ||
Yes | 37 (9 %) | 45 (4 %) | ||
Tumor grade, Elston | <0.001 | 42 % | ||
1 | 35 (16 %) | 147 (25 %) | ||
2 | 109 (50 %) | 323 (54 %) | ||
3 | 75 (34 %) | 127 (21 %) | ||
ER status | <0.001 | 27 % | ||
Negative | 57 (19 %) | 72 (10 %) | ||
Positive | 239 (81 %) | 659 (90 %) | ||
PR status | 0.002 | 28 % | ||
Negative | 109 (38 %) | 201 (28 %) | ||
Positive | 181 (62 %) | 520 (72 %) |